1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Autor:	Lore Decoster, Martin Sebastian, D. A. Clump, S. M. Galdy, Egbert F. Smit, K. F. Mileham, Luis Paz-Ares, A. Estival, Enriqueta Felip, N. Vinolas Segarra, Martin Reck, Veerle Surmont, Andrea Wagner, P. Fried
Rok vydání:	2020
Předmět:	Oncology Radium-223 medicine.medical_specialty business.industry Hematology Pembrolizumab Stage IV non-small cell lung cancer Phase i ii Internal medicine Medicine In patient business medicine.drug
Zdroj:	Annals of Oncology. 31:S897-S898
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.1734
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::98f3c23f1084422c645397eab16a4dae https://doi.org/10.1016/j.annonc.2020.08.1734 Zobrazit plný text záznamu